San Francisco, CA, United States of America

Kurt Eulau

This inventor holds 2 USPTO granted patents and 8 published patent applications. Top assignee: Calmwave, Inc.. Active years: 2026.

USPTO Granted Patents = 2 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kurt Eulau: Innovator in Information Management Systems

Introduction

Kurt Eulau is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of information management systems, particularly in medical environments. With a total of 2 patents, Eulau's work focuses on enhancing patient care through innovative technology.

Latest Patents

Eulau's latest patents include a computer-implemented method and system for monitoring data signals associated with patients. One of his patents involves generating a shift-change report that summarizes the medical history of patients over a defined period. This report also includes recommendations based on the patients' histories and justifications for those recommendations. Another patent focuses on calculating acuity scores for multiple patients, which helps prioritize their care needs. This system generates a rounding list based on these acuity scores, ensuring that patients receive timely attention.

Career Highlights

Kurt Eulau is currently associated with Calmwave, Inc., where he continues to develop innovative solutions in healthcare technology. His work has been instrumental in improving the efficiency of patient monitoring and care management.

Collaborations

Eulau collaborates with talented individuals such as Ophir Ronen and Justin Kearns, contributing to a dynamic team focused on advancing medical technology.

Conclusion

Kurt Eulau's contributions to information management systems reflect his commitment to improving patient care through technology. His innovative patents and collaborative efforts position him as a key figure in the field of healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…